XML 21 R7.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities    
Net loss $ (4,480) $ (13,282)
Adjustments to reconcile net loss to net cash used in operating activities:    
Credit loss expense 335 643
Depreciation and amortization 4,418 6,291
Amortization of financing costs charged to interest expense 330 405
Amortization of right-of-use assets 322 632
Gain on divestiture (14,543)  
Gain on divestiture 0 (5,350)
Stock-based compensation expense 4,828 8,694
Change in contingent consideration 0 (60)
Loss on investments 1,285 0
Other non-cash expense (income), net 1,764 (2,620)
Change in operating assets and liabilities:    
Accounts receivable 18,316 7,536
Prepaid expenses and other assets 154 (56)
Accounts payable (167) 551
Other accrued expenses 586 1,895
Partner Share liability (7,238) (3,860)
Consumer Incentive liability (11,552) (8,245)
Net cash used in operating activities (5,642) (6,706)
Investing activities    
Acquisition of property and equipment (28) (119)
Capitalized software development costs (2,276) (3,984)
Proceeds from divestiture, net of cash divested 0 200
Net cash used in investing activities (2,304) (3,903)
Financing activities    
Proceeds from issuance of debt 5,000 0
Settlement of contingent consideration 0 (3,000)
Principal payment of debt (10,000) 0
Debt issuance costs (22) (34)
Net cash used in financing activities (5,022) (3,034)
Effect of exchange rates on cash and cash equivalents (78) 95
Net decrease in cash and cash equivalents (13,046) (13,548)
Cash and cash equivalents — Beginning of period 48,719 65,594
Cash and cash equivalents — End of period 35,673 52,046
Supplemental disclosure of cash flow information:    
Cash paid for interest 625 253
Amounts accrued for property and equipment 0 171
Amounts accrued for capitalized software development costs $ 39 $ 187